Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) as a target for anti-amoebic agents

21Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: The current use of metronidazole as an anti-amoebic agent causes significant side-effects. The purpose of this study was to identify alternative compounds with which to treat amoeblasis. Methods: We tested the effects of cyclopropyl (CPC) and cyclobutyl (CBC) carbinols on the survival of Entamoeba histolytica trophozoites and on the enzymatic activities of E. histolytica alcohol dehydrogenase, 2 (EhADH2), a crucial enzyme in the amoebic fermentation pathway. Results: At 72 h, the estimated 50% inhibitory concentrations of CPC and CBC were 38.9 and 11.2 μM, respectively. The EhADH2 alcohol and aldehyde dehydrogenase activities were inhibited by 1.82 μM CPC and 0.89 μM CBC in vitro. Conclusions: CPC and CBC are expected to be non-toxic to humans at the concentrations required to eliminate E. histolytica trophozoites. Similarities between EhADH2 and the Giardia lamblia AdhE enzyme indicate that CPC and CBC could be effective drugs for treatment of both amoebiasis and giardiasis. © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.

Cite

CITATION STYLE

APA

Espinosa, A., Clark, D., & Stanley, S. L. (2004). Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) as a target for anti-amoebic agents. Journal of Antimicrobial Chemotherapy, 54(1), 56–59. https://doi.org/10.1093/jac/dkh280

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free